BioNTech (BNTX) PT Lowered to $136 at Canaccord
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $98.66 -4.92%
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 1 | New: 13
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 1 | New: 13
Join SI Premium – FREE
Canaccord analyst William Maughan lowered the price target on BioNTech (NASDAQ: BNTX) to $136.00 (from $142.00) while maintaining a Buy rating.
You May Also Be Interested In
- BMO Capital Downgrades BioNTech (BNTX) to Market Perform
- BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
- JCDecaux SA (DEC:FP) (JCDXF) PT Raised to EUR34 at JPMorgan, Placed on Positive Catalyst Watch
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
